アプタマー アフェレシス 核酸医薬の開発|タグシクス・バイオ株式会社

Patents, Articles & Conferences

  • Home
  • News
  • Patents, Articles & Conferences

Announcement of presentation at the 9th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan (July 15th – 18th, 2024)

The 9th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan
July 15-18th, 2024 / SENDAI Internatioal Center
Session Date / Time : July 18th, 2024 / 12:15 PM to 12:45 PM

Chizuko Koseki (President & CEO, TAGCyx Biotechnologies, Inc, Meguro, Tokyo, Japan)
Development of Next Generation Apheresis column using Artificial base DNA Aptamer as a specific ligand; for the Treatment of Preeclampsia“.